SEOUL, South Korea, March 19, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) in a phase 1b clinical...
Hence then, the article about gi innovation announces first clinical supply agreement to explore combination therapy for prostate cancer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer )
Also on site :
- Fireworks light up New York City to mark 250 years of US independence
- Adidas' 'Comfortable' Slide Sandals 'Mold to Your Feet,' and They're on Sale for Just $20 at JCPenney
- WWE: Liv Morgan confirms relationship with boyfriend Landon Hardwick amid engagement rumors